Harris McFerrin, PhD

Harris McFerrin, PhD

Associate Professor

Dr. Harris McFerrin received a Bachelor’s of Science degree in Biology and Computer-Based Honors from the University of Alabama in 1995 and then a Master of Science degree in the laboratory of Dr. Richard Marchase at the University of Alabama at Birmingham Cell Biology Department in 1999.  During this time, he was awarded the Buris Boschell Scholarship in Medicine and was a visiting scientist in the laboratory of Dr. Frans Nijkamp, Utrecht, the Netherlands.  Upon completion of his Master’s degree, Dr. McFerrin moved to New Orleans to attend Tulane University.  In 2006, he earned is Doctorate of Philosophy degree in Molecular and Cellular Biology under the guidance of Dr. Cindy Morris.  His Ph.D. thesis project focused on the molecular mechanisms of cyclin-dependent kinase 9 and NF-κB in angiogenesis. For his postdoctoral training, Dr. McFerrin examined the vascular trafficking of human multipotent mesenchymal stem cells in the laboratory of Dr. Darwin Prockop.  Dr. McFerrin is currently an Assistant Professor at Xavier University of Louisiana and an adjunct Assistant Professor of Microbiology and Immunology at Tulane University.  He is also a member of both the Louisiana Cancer Research and the Louisiana Gene Therapy Research Consortia.

Education: BS, University of Alabama, MS. University of     Alabama Birmingham, PhD. Tulane University

ORCID identifier: 0000-0001-7261-6320

MyNCBI Link: https://www.ncbi.nlm.nih.gov/myncbi/1p3Fqdzmsazkr/bibliography/public/

Selected Publications:

 

Schexnayder C, Broussard K, Onuaguluchi D, Poché A, Ismail M, McAtee L, Llopis S, Keizerweerd A, McFerrin H, Williams C. Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2Expression in MDA-MB-231 Breast Cancer Cells. Int J Mol Sci. 2018 Nov 21;19(11). doi:10.3390/ijms19113692. PubMed PMID: 30469399;PubMed Central PMCID: PMC6274682.

 

AngelovaM, Ferris M, Swan KF, McFerrin HE, Pridjian G, Morris CA, Sullivan DE. Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway. VirolJ. 2014Dec 17;11:218. doi:10.1186/s12985-014-0218-8. PubMed PMID: 25514828; PubMed Central PMCID: PMC4304609.



ZhengS, Zhong Q, Xi Y, Mottamal M, Zhang Q, Schroeder RL, Sridhar J, He L, McFerrinH, Wang G. Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion. J Med Chem. 2014 Aug 14;57(15):6653-67. doi: 10.1021/jm500724x. Epub 2014 Jul 18. PubMed PMID: 25007006; PubMed Central PMCID: PMC4136724.



Zheng S, Zhong Q, Mottamal M, Zhang Q, Zhang C, Lemelle E, McFerrin H, Wang G. Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents. J Med Chem. 2014 Apr 24;57(8):3369-81. doi: 10.1021/jm500002k. Epub 2014 Apr 7. PubMed PMID: 24669888; PubMed Central PMCID: PMC4002123.



Abboud ER, Shelby BD, Angelova M, Nelson AB, FerrisM, McFerrin HE, Morris CA, Sullivan DE. Kaposi sarcoma-associated herpesvirus g protein-coupled receptor enhances endothelial cell survival in part by upregulation ofbcl-2. OchsnerJ. 2013 Spring;13(1):66-75. PubMed PMID: 23532945; PubMed Central PMCID: PMC3603191.


Keywords/Tags: CMV KSHV transcriptomics

LCRC Faculty

Jayalakshmi Sridhar PhD
Translational Oncology
Xavier University
Shang Su, Phd
Cancer Biology
LSU School of Veterinary Medicine
Kevin Sullivan, MD
Cancer Biology
LSU Health - New Orleans
Gulshan Sunavala-Dossabhoy, PhD
Translational Oncology
LSU Health - New Orleans
Paul Sylvester PhD
Cancer Biology
University of Louisiana Monroe
Xiaochao Tan, PhD
Cancer Biology
Tulane University School of Medicine
Paul Thevenot, PhD
Translational Oncology
Ochsner Health
Raju Thomas MD
Translational Oncology
Tulane University School of Medicine
Aiguo Tian PhD
Cancer Biology
Tulane University School of Medicine